Joel Claveau
Chercheur associé
Axe Oncologie
Publications
View all-
article Fournier C, Sauder MB, Claveau J, Butler MO, Hijal T, Dayeh NR, Lynde CW
CaSMO Recommendations for Prevention and Treatment of Cutaneous Adverse Events Related to Cancer Therapies in Darker Skin Phototypes
Clin Cosmet Investig Dermatol 18 2025.
-
article Chergui M, Redpath M, Wang CS, Mlynarek A, Esfahani K, Thibaudeau S, Sultanem K, Claveau J
Guidelines for Clinicians and Pathologists on Performing Skin Biopsies and Reporting on Suspected Cutaneous Squamous Cell Carcinoma
Curr Oncol 32 (12), 2025.
-
article Papp KA, Puig L, Beecker J, Chandran V, Claveau J, Cortés J, Dutz J, Hornick NI, Juergens RA, Melosky B, Patel AB, Sauder MB, Sehdev S, Sibaud V, Snow SL
Systemic treatment of immune checkpoint inhibitor-induced psoriasis: Inference-based guidance
J Eur Acad Dermatol Venereol 39 (11), 2025.
Projects
- A Phase 3, Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled Clinical study of Adjuvant V940 (mRNA-4157) Plus Pembrolizumab Versus Adjuvant Placebo Plus Pembrolizumab in Participants With High-Risk Stage II-IV Melanoma, from 2023-09-14 to 2028-12-25
- Révision de cas de patients opérés par la technique de chirurgie dermatologique de type Slow Mohs pour un mélanome de type lentigo malin, from 2023-04-01 to 2026-03-31